Predicting clinically significant prostate cancer with or without digital rectal exam and MRI data using ClarityDX Prostate models
Robert J. Paproski, Adam Kinnaird, M. Eric Hyndman, Adrian Fairey et autres
0 citationsnpj Digital Medicine
Armen Aprikian
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
427Publications signalées
15711Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesCancer, Lipids, and Metabolism
Publications récentes
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts
Ashwini Uchil, Louis Lacombe, Hélène Hovington, Hervé Brisson et autres
2 citationsEuropean Urology Oncology
Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysis
Armen Aprikian, Andrew Chilelli, Thomas W. McLean, Anchen F. Nasr et autres
0 citationsFrontiers in Oncology
2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update)
Fred Saad, Alan So, Armen Aprikian, Antonio Finelli et autres
1 citationCanadian Urological Association Journal
Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate Cancer
Samira Rahimirad, Seta Derderian, Lucie Hamel, Eleonora Scarlata et autres
4 citationsInternational Journal of Molecular Sciences
Cost-effectiveness of enzalutamide with androgen-deprivation therapy (ADT) versus ADT alone for the treatment of high-risk biochemically recurrent non-metastatic castration-sensitive prostate cancer in Canada
Armen Aprikian, Fred Saad, Ewa Wywiał, Thomas W. McLean et autres
3 citationsJournal of Medical Economics
Cost-Effectiveness Analysis of Contemporary Advanced Prostate Cancer Treatment Sequences
Valentyn Litvin, Armen Aprikian, Alice Dragomir
4 citationsCurrent Oncology
Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada
Steven Yip, Winson Y. Cheung, Armen Aprikian, Matthias Stoelzel et autres
3 citationsFuture Oncology
Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study
Axel S. Merseburger, Eugen Dornstauder, Carsten‐Henning Ohlmann, Armen Aprikian et autres
7 citationsAdvances in Therapy
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
Armen Aprikian, Amit Bahl, Aurelius Omlin, Giulia Baciarello et autres
5 citationsFrontiers in Oncology
Reply by Authors
Cylia Dahmani, Patrick Caron, David Simonyan, Louis Lacombe et autres
0 citationsThe Journal of Urology
Clinical significance of stratifying prostate cancer patients through specific circulating genes
Seta Derderian, Edouard Jarry, Arynne Santos, Quentin Vesval et autres
1 citationMolecular Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.